-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Acer Therapeutics Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
- Acer Therapeutics Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$14.7M, a 194% decline year-over-year.
- Acer Therapeutics Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$48.5M, a 128% decline year-over-year.
- Acer Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$26.2M, a 70.7% decline from 2021.
- Acer Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$15.4M, a 32.8% increase from 2020.
- Acer Therapeutics Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$22.9M, a 22.2% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)